SEARCH

SEARCH BY CITATION

References

  • Ageno, W., Becattini, C., Brighton, T., Selby, R. & Kamphuisen, P.W. (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation, 117, 93102.
  • Van Aken, B.E., Reitsma, P.H. & Rosendaal, F.R. (2002) Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. British Journal of Haematology, 116, 173177.
  • Andreou, E.R., Koru-Sengul, T., Linkins, L., Bates, S.M., Ginsberg, J.S. & Kearon, C. (2008) Differences in clinical presentation of deep vein thrombosis in men and women. Journal of Thrombosis and Haemostasis, 6, 17131719.
  • Annual Review of Civil Aviation. (2006) International Civil Aviation Organization Journal, 61, 144.
  • Baccarelli, A., Martinelli, I., Pegoraro, V., Melly, S., Grillo, P., Zanobetti, A., Hou, L., Bertazzi, P.A., Mannucci, P.M. & Schwartz, J. (2009) Living near major traffic roads and risk of deep vein thrombosis. Circulation, 119, 31183124.
  • Baglin, T., Luddington, R., Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523526.
  • Bank, I., Van De Poel, M.H., Coppens, M., Hamulyák, K., Prins, M.H., Van Der Meer, J., Veeger, N.J., Büller, H.R. & Middeldorp, S. (2007) Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Thrombosis and Haemostasis, 98, 10401044.
  • Bates, S.M., Greer, I.A., Pabinger, I., Sofaer, S. & Hirsh, J. (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133(Suppl. 6), 844S886S.
  • Bezemer, I.D., Bare, L.A., Doggen, C.J., Arellano, A.R., Tong, C., Rowland, C.M., Catanese, J., Young, B.A., Reitsma, P.H., Devlin, J.J. & Rosendaal, F.R. (2008) Gene variants associated with deep vein thrombosis. Journal of the American Medical Association, 299, 13061314.
  • Blom, J.W., Doggen, C.J., Osanto, S. & Rosendaal, F.R. (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. Journal of the American Medical Association, 293, 715722.
  • Brouwer, J.L., Bijl, M., Veeger, N.J., Kluin-Nelemans, H.C. & Van Der Meer, J. (2004) The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood, 104, 143148.
  • Brouwer, J.L., Veeger, N.J., Kluin-Nelemans, H.C. & Van Der Meer, J. (2006) The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Annals of Internal Medicine, 145, 807815.
  • Brummel-Ziedins, K.E., Vossen, C.Y., Butenas, S., Mann, K.G. & Rosendaal, F.R. (2005) Thrombin generation profiles in deep venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 24972505.
  • Cannegieter, S.C., Doggen, C.J., Van Houwelingen, H.C. & Rosendaal, F.R. (2006) Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Medicine, 3, e307.
  • Chandra, D., Parisini, E. & Mozaffarian, D. (2009) Meta-analysis: travel and risk for venous thromboembolism. Annals of Internal Medicine, 151, 180190.
  • Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. & Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. Journal of the American Medical Association, 293, 23522361.
  • Christiansen, S.C., Naess, I.A., Cannegieter, S.C., Hammerstrøm, J., Rosendaal, F.R. & Reitsma, P.H. (2006) Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Medicine, 3, e334.
  • Cogo, A., Lensing, A.W., Prandoni, P. & Hirsh, J. (1993) Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Archives of Internal Medicine, 153, 27772780.
  • Cushman, M., Glynn, R.J., Goldhaber, S.Z., Moll, S., Bauer, K.A., Deitcher, S., Shrivastava, S. & Ridker, P.M. (2006) Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. Journal of Thrombosis and Haemostasis, 4, 21992203.
  • De Stefano, V., Martinelli, I., Rossi, E., Battaglioli, T., Za, T., Mannuccio Mannucci, P. & Leone, G. (2006) The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. British Journal of Haematology, 135, 386391.
  • Deslandes, M. (1759) Traité des Accouchements de M. Puzos. Desaint & Saillant, Paris.
  • Doggen, C.J., Berckmans, R.J., Sturk, A., Manger Cats, V. & Rosendaal, F.R. (2000) C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men. Journal of Internal Medicine, 248, 406414.
  • Eischer, L., Eichinger, S. & Kyrle, P.A. (2009) Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. Medicine (Baltimore), 88, 366370.
  • Faioni, E.M., Valsecchi, C., Palla, A., Taioli, E., Razzari, C. & Mannucci, P.M. (1997) Free protein S deficiency is a risk factor for venous thrombosis. Thrombosis and Haemostasis, 78, 13431346.
  • Franco, R.F., Reitsma, P.H., Lourenço, D., Maffei, F.H., Morelli, V., Tavella, M.H., Araújo, A.G., Piccinato, C.E. & Zago, M.A. (1999) Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thrombosis and Haemostasis, 81, 676679.
  • Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R. & Colwell, C.W.; American College of Chest Physicians. (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133(Suppl. 6), 381S453S.
  • Ginsberg, J.S., Wells, P.S., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P. & Hirsh, J. (1995) Antiphospholipid antibodies and venous thromboembolism. Blood, 86, 36853691.
  • Glynn, R.J. & Rosner, B. (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. American Journal of Epidemiology, 162, 975982.
  • Grainge, M.J., West, J. & Card, T.R. (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet, 375, 657663.
  • Greenland, S., Pearl, J. & Robins, J.M. (1999) Causal diagrams for epidemiologic research. Epidemiology, 10, 3748.
  • Grodstein, F., Stampfer, M.J., Goldhaber, S.Z., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. & Hennekens, C.H. (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet, 348, 983987.
  • Hansson, P.O., Sörbo, J. & Eriksson, H. (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Archives of Internal Medicine, 160, 769774.
  • Heijboer, H., Brandjes, D.P., Büller, H.R., Sturk, A. & Ten Cate, J.W. (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New England Journal of Medicine, 323, 15121516.
  • Den Heijer, M., Koster, T., Blom, H.J., Bos, G.M., Briet, E., Reitsma, P.H., Vandenbroucke, J.P. & Rosendaal, F.R. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334, 759762.
  • Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., Lohse, C.M., O’Fallon, W.M. & Melton, 3rd, L.J. (2001) The epidemiology of venous thromboembolism in the community. Thrombosis and Haemostasis, 86, 452463.
  • Heit, J.A., Leibson, C.L., Ashrani, A.A., Petterson, T.M., Bailey, K.R. & Melton, 3rd, L.J. (2009) Is diabetes mellitus an independent risk factor for venous thromboembolism?: A population-based case-control study. Arteriosclerosis Thrombosis and Vascular Biology, 29, 13991405.
  • Van Hylckama Vlieg, A. & Rosendaal, F.R. (2003) Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis. Journal of Thrombosis and Haemostasis, 1, 21862190.
  • Van Hylckama Vlieg, A., Van Der Linden, I.K., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood, 95, 36783682.
  • Jick, H., Slone, D., Westerholm, B., Inman, W.H., Vessey, M.P., Shapiro, S., Lewis, G.P. & Worcester, J. (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet, 1, 539542.
  • Kakkar, V.V., Howe, C.T., Nicolaides, A.N., Renney, J.T. & Clarke, M.B. (1970) Deep vein thrombosis of the leg. Is there a “high risk” group?. American Journal of Surgery, 120, 527530.
  • Kierkegaard, A. (1983) Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 62, 239243.
  • Koster, T., Rosendaal, F.R., De Ronde, H., Briët, E., Vandenbroucke, J.P. & Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 15031506.
  • Koster, T., Rosendaal, F.R., Reitsma, P.H., Van Der Velden, P.A., Briët, E. & Vandenbroucke, J.P. (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS). Thrombosis and Haemostasis, 71, 719722.
  • Koster, T., Blann, A.D., Briët, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152155.
  • Kuipers, S., Cannegieter, S.C., Middeldorp, S., Robyn, L., Büller, H.R. & Rosendaal, F.R. (2007a) The absolute risk of venous thrombosis after air travel: a cohort study of 8 755 employees of international organisations. PLoS Medicine, 4, e290.
  • Kuipers, S., Schreijer, A.J., Cannegieter, S.C., Büller, H.R., Rosendaal, F.R. & Middeldorp, S. (2007b) Travel and venous thrombosis: a systematic review. Journal of Internal Medicine, 262, 615634.
  • Kuipers, S., Cannegieter, S.C., Doggen, C.J. & Rosendaal, F.R. (2009) Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers. Blood, 113, 20642069.
  • Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. & Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457462.
  • Kyrle, P.A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A. & Eichinger, S. (2004) The risk of recurrent venous thromboembolism in men and women. New England Journal of Medicine, 350, 25582563.
  • Lapostolle, F., Surget, V., Borron, S.W., Desmaizières, M., Sordelet, D., Lapandry, C., Cupa, M. & Adnet, F. (2001) Severe pulmonary embolism associated with air travel. New England Journal of Medicine, 345, 779783.
  • Lawlor, D.A., Harbord, R.M., Timpson, N.J., Lowe, G.D., Rumley, A., Gaunt, T.R., Baker, I., Yarnell, J.W., Kivimäki, M., Kumari, M., Norman, P.E., Jamrozik, K., Hankey, G.J., Almeida, O.P., Flicker, L., Warrington, N., Marmot, M.G., Ben-Shlomo, Y., Palmer, L.J., Day, I.N., Ebrahim, S. & Smith, G.D. (2008) The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4 610 cases amongst 18 637 participants. PLoS ONE, 3, e3011.
  • Lijfering, W.M. & Van Der Meer, J. (2009) Pharmacological prevention of venous thromboembolism. In: Deep Vein Thrombosis and Pulmonary Embolism (ed. by E.J.Van Beek, H.R.Büller & M.Oudkerk), 2nd edn, pp. 435461. John Wiley and Sons, Chicester.
  • Lijfering, W.M., Brouwer, J.L., Veeger, N.J., Bank, I., Coppens, M., Middeldorp, S., Hamulyák, K., Prins, M.H., Büller, H.R. & Van Der Meer, J. (2009a) Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood, 113, 53145322.
  • Lijfering, W.M., Veeger, N.J., Middeldorp, S., Hamulyák, K., Prins, M.H., Büller, H.R. & Van Der Meer, J. (2009b) A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood, 114, 20312036.
  • Lisman, T., De Groot, P.G., Meijers, J.C. & Rosendaal, F.R. (2005) Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood, 105, 11021105.
  • Mahmoodi, B.K., Brouwer, J.L., Veeger, N.J. & Van Der Meer, J. (2008a) Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation, 118, 16591667.
  • Mahmoodi, B.K., Ten Kate, M.K., Waanders, F., Veeger, N.J., Brouwer, J.L., Vogt, L., Navis, G. & Van Der Meer, J. (2008b) High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation, 117, 224230.
  • Mahmoodi, B.K., Gansevoort, R.T., Veeger, N.J., Matthews, A.G., Navis, G., Hillege, H.L. & Van Der Meer, J., Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group. (2009) Microalbuminuria and risk of venous thromboembolism. Journal of the American Medical Association, 301, 17901797.
  • Malone, C.P. & Agutter, P.S. (2008) The Aetiology of Deep Venous Thrombosis: A Critical, Historical and Epistemiological Survey, 1st edn. Springer Science + Business Media B.V., Houten, The Netherlands.
  • Mannucci, P.M. (2002) Venous thrombosis: the history of knowledge. Pathophysiology of Haemostasis and Thrombosis, 32, 209212.
  • McColl, M.D., Ramsay, J.E., Tait, R.C., Walker, I.D., McCall, F., Conkie, J.A., Carty, M.J. & Greer, I.A. (1997) Risk factors for pregnancy associated venous thromboembolism. Thrombosis and Haemostasis, 78, 11831188.
  • McRae, S., Tran, H., Schulman, S., Ginsberg, J. & Kearon, C. (2006) Effect of patient’s sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet, 368, 371378.
  • Meijers, J.C., Tekelenburg, W.L., Bouma, B.N., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696701.
  • Middeldorp, S. & Van Hylckama Vlieg, A. (2008) Does thrombophilia testing help in the clinical management of patients? British Journal of Haematology, 143, 321335.
  • Morabia, A. (2004). Epidemiology: an epistemological perspective. In: History of Epidemiological Methods and Concepts (ed. by A.Morabia), pp. 1126. Birkhauser, Basel.
  • Naess, I.A., Christiansen, S.C., Romundstad, P., Cannegieter, S.C., Rosendaal, F.R. & Hammerstrøm, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692699.
  • Nicolaides, A., Irving, D., Pretzell, M., Dupont, P., Lewis, J., Desai, S., Douglas, J.N., Kakkar, V.V. & Field, E.S. (1973) The risk of deep-vein thrombosis in surgical patients. British Journal of Surgery, 60, 312.
  • Pengo, V. & Prandoni, P. (2006) Sex and anticoagulation in patients with idiopathic venous thromboembolism [letter]. Lancet, 368, 342343.
  • Poli, D., Zanazzi, M., Antonucci, E., Bertoni, E., Salvadori, M., Abbate, R. & Prisco, D. (2006) Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. Journal of Thrombosis and Haemostasis, 4, 988992.
  • Pomp, E.R., Le Cessie, S., Rosendaal, F.R. & Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 139, 289296.
  • Pomp, E.R., Rosendaal, F.R. & Doggen, C.J. (2008) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology, 83, 97102.
  • Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 36983703.
  • Prandoni, P., Noventa, F., Ghirarduzzi, A., Pengo, V., Bernardi, E., Pesavento, R., Iotti, M., Tormene, D., Simioni, P. & Pagnan, A. (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1 626 patients. Haematologica, 92, 199205.
  • Quist-Paulsen, P., Naess, I.A., Cannegieter, S.C., Romundstad, P.R., Christiansen, S.C., Rosendaal, F.R. & Hammerstrøm, J. (2010) Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica, 95, 119125.
  • Rosendaal, F.R. (1999) Venous thrombosis: a multicausal disease. Lancet, 353, 11671173.
  • Rosendaal, F.R. (2006) Interventions to prevent venous thrombosis after air travel: are they necessary? No. Journal of Thrombosis and Haemostasis, 4, 23062307.
  • Rosendaal, F.R. (2009) Causes of Venous Thrombosis. In: Deep Vein Thrombosis and Pulmonary Embolism (ed. by E.J.Van Beek, H.R.Büller & M.Oudkerk), 2nd ed. pp. 126. John Wiley and Sons, Chichester.
  • Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. & Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 15041508.
  • Rothman, K.J. (2002). Types of Epidemiologic study. In: Epidmiology: An Introduction (ed. by K.J.Rothman), 1st ed, pp. 5793. Oxford University Press Inc., New York, NY.
  • Roumen-Klappe, E.M., Janssen, M.C., Van Rossum, J., Holewijn, S., Van Bokhoven, M.M., Kaasjager, K., Wollersheim, H. & Den Heijer, M. (2009) Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. Journal of Thrombosis and Haemostasis, 7, 582587.
  • Sackett, D.L. (1979) Bias in analytic research. Journal of Chronic Diseases, 32, 5163.
  • Sartwell, P.E., Masi, A.T., Arthes, F.G., Greene, G.R. & Smith, H.E. (1969) Thromboembolism and oral contraceptives: an epidemiologic case-control study. American Journal of Epidemiology, 90, 365380.
  • Sarvesvaran, R. (1986) Sudden natural deaths associated with commercial air travel. Medicine, Science, and the Law, 26, 3538.
  • Simioni, P., Sanson, B.J., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Huisman, M.V., Büller, H.R., Wouter ten Cate, J., Girolami, A. & Prins, M.H. (1999) Incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis and Haemostasis, 81, 198202.
  • Smeeth, L., Cook, C., Thomas, S., Hall, A.J., Hubbard, R. & Vallance, P. (2006) Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 367, 10751079.
  • Smith, N.L., Hindorff, L.A., Heckbert, S.R., Lemaitre, R.N., Marciante, K.D., Rice, K., Lumley, T., Bis, J.C., Wiggins, K.L., Rosendaal, F.R. & Psaty, B.M. (2007) Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. Journal of the American Medical Association, 297, 489498.
  • Sullivan, P.S., Dworkin, M.S., Jones, J.L. & Hooper, W.C. (2000) Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS, 14, 321324.
  • Van Tilburg, N.H., Rosendaal, F.R. & Bertina, R.M. (2000) Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood, 95, 28552859.
  • Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Polak, J.F. & Folsom, A.R. (2002) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine, 162, 11821189.
  • Virchow, R. (1856) Phlogose und Trombose im Gefäßystem Fesammelte Abhandelungen zur Wissenschaftlichen Medizin. Staatsdruckerei, Frankfurt Germany.
  • Van Vlijmen, E.F., Brouwer, J.L., Veeger, N.J., Eskes, T.K., De Graeff, P.A. & Van Der Meer, J. (2007) Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Archives of Internal Medicine, 167, 282289.
  • Vossen, C.Y., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, F.J., Pabinger, I., Palareti, G., Preston, F.E., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. & Rosendaal, F.R. (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis, 3, 459464.
  • Wattanakit, K., Cushman, M., Stehman-Breen, C., Heckbert, S.R. & Folsom, A.R. (2008) Chronic kidney disease increases risk for venous thromboembolism. Journal of the American Society of Nephrology, 19, 135140.
  • Van Zaane, B., Squizzato, A., Huijgen, R., Van Zanten, A.P., Fliers, E., Cannegieter, S.C., Büller, H.R., Gerdes, V.E. & Brandjes, D.P. (2010) Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood, doi: 10.1182/blood-2009-11-253724.
  • Zhu, T., Martinez, I. & Emmerich, J. (2009) Venous thromboembolism: risk factors for recurrence. Arteriosclerosis Thrombosis and Vascular Biology, 29, 298310.